2019 Edition of the CRO Market Size Projections: 2018-2023 - ResearchAndMarkets.com

DUBLIN--()--The "2019 Edition of the CRO Market Size Projections: 2018-2023" report has been added to ResearchAndMarkets.com's offering.

2018 was a decent, not spectacular, year for CROs. We witnessed year-over-year revenue growth from all the major/public CROs. Yet, the major publicly traded CROs took a pause, along with the rest of the market. Remember, the S&P 500 fell by ~6% in 2018, so the fact that most of the public CROs managed to gain is a win.

The biopharmaceutical fundamentals stayed intact and CROs were able to take advantage. This report gives quantitative insight into the perpetual question: What is the size of the CRO market? The data provide a thorough, rational perspective for clinical development services segmented by phase, geography, and service line.

Estimated R&D expenditures through 2023

Projected spending on development, Phase I-IV development, and outsourced Phase I-IV development through 2023, segmented by sponsor type:

  • Large pharma - large molecule
  • Large pharma - small molecule
  • Non-large pharma - large molecule
  • Non-large pharma - small molecule
  • Generic/Specialty
  • Government
  • Private
  • Association/Non-profit
  • Academic

Spending on CRO services segmented by:

  • Geography
  • Service-line
  • Phase I-IV

Major Topics:

  • Overall Market Size and Growth
  • 2019 Geographic Assessment
  • 2019 Service-line Assessment
  • 2019 Development Phase I-IV Assessment
  • 2018-2023 CRO Market Model
  • 2018-2023 CRO Market Model - Growth Rates
  • 2019 Public CRO Market Share

For more information about this report visit https://www.researchandmarkets.com/r/83x0ml

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900